Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
China Halts UCB's Keppra Injection Sales
Domestics Generics Capturing Share
24 Aug 2022
•
By
Brian Yang
China halts import, sales and use of the widely prescribed epilepsy drug.
CHINA HALTS UCB'S ANTI-EPILEPSY KEPPRA INJECTION SALES • Source: Shutterstock
More from Business
More from Scrip